Updated 2026-09-08 · NCT07392190See eligibility →
City
Clinical trials near Luoyang Shi, China
Active studies with a listed research site in Luoyang Shi, China.
13active studies
3recruiting now
11countries represented
187largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Updated 2026-09-08 · NCT07282600See eligibility →
Updated 2026-09-08 · NCT07369011See eligibility →
Updated 2026-08-31 · NCT07794579See eligibility →
Updated 2026-08-27 · NCT07790861See eligibility →
Updated 2026-08-14 · NCT05869903See eligibility →
Updated 2026-07-31 · NCT06993792See eligibility →
Updated 2026-07-29 · NCT06972459See eligibility →
Updated 2026-05-29 · NCT06948422See eligibility →
Updated 2026-05-29 · NCT06948435See eligibility →
Updated 2026-05-29 · NCT06952530See eligibility →
Active, not recruitingPhase 3
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Updated 2026-04-20 · NCT06972472See eligibility →
Active, not recruitingPhase 3
A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Updated 2025-09-29 · NCT06649045See eligibility →
Related cities
Beijing, China123Boston, United States76Houston, United States75Shanghai, China74Chicago, United States70New York, United States59
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.